tirzepatide semaglutide equivalent vs Semaglutide: Key Differences Explained Tirzepatide & Semaglutide Weight Loss

Other less common side effects include: While semaglutide is generally considered safe, there are some precautions to keep in mind

doi:10.1002/dmr.11245 Drugs.com

Highlights from Novo Nordisks presentation include (see Figure 1): Analysis of the three components in MACE: Semaglutide 2.4 mg reduced the risk of Non-fatal myocardial infarction by 28% Cardiovascular death by 15% (not statistically significant over the length of the trial) Non-fatal stroke by 7% (not statistically significant over the length of the trial) Analysis of confirmatory secondary endpoints: Semaglutide 2.4 mg reduced the risk of Composite heart failure events, comprising cardiovascular death, urgent heart failure visits and hospitalisations, by 18% Death from any cause by 19% Note: Since the result on cardiovascular death, the first confirmatory secondary endpoint, was not statistically significant over the length of the trial, the remaining secondary confirmatory endpoints were not tested for superiority due to hierarchical testing

It may take more than one try to find the best fit for your weight goals